cifenline has been researched along with Hypertrophy, Left Ventricular in 2 studies
Hypertrophy, Left Ventricular: Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.
| Excerpt | Relevance | Reference |
|---|
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ochiumi, Y | 1 |
| Ikeda, S | 2 |
| Hamada, M | 2 |
| Ohshima, K | 1 |
| Nakamura, M | 1 |
| Kubota, N | 1 |
| Ogimoto, A | 1 |
| Shigematsu, Y | 1 |
2 other studies available for cifenline and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Reappearance of the left ventricular pressure gradient in a patient with hypertrophic obstructive cardiomyopathy.
Topics: Aged, 80 and over; Anti-Arrhythmia Agents; Chest Pain; Female; Humans; Hypertrophy, Left Ventricular | 2015 |
Impact of chronic use of cibenzoline on left ventricular pressure gradient and left ventricular remodeling in patients with hypertrophic obstructive cardiomyopathy.
Topics: Aged; Anti-Arrhythmia Agents; Cardiomyopathy, Hypertrophic; Echocardiography; Electrocardiography; F | 2016 |